EGFR rs121913428: Gene Variant and Cancer Treatment
The genetic variant rs121913428 is a specific change located within the Epidermal Growth Factor Receptor (EGFR) gene. This variant has been studied for its potential association with clinical responses to certain cancer therapies.
What each genotype means
Typical EGFR gene profile
This genotype represents the common, non-mutated sequence at this position in the EGFR gene. It is considered the reference sequence in the general population and is not associated with the specific oncogenic changes linked to this variant. Please note that this profile refers only to this specific genetic location.
This is the most common genotype found in the general population.
EGFR variant carrier
This genotype indicates the presence of one copy of the variant allele, which is associated with specific clinical responses in oncology, particularly in the context of non-small cell lung cancer. Research suggests this variant can influence sensitivity to certain targeted therapies known as EGFR tyrosine kinase inhibitors. You should discuss the clinical implications of this finding and any potential impact on treatment options with your oncologist or a qualified healthcare provider.
This genotype is rare in the general population.
EGFR variant carrier
This genotype indicates the presence of two copies of the variant allele, which is associated with specific clinical responses in oncology, particularly in the context of non-small cell lung cancer. Research suggests this variant can influence sensitivity to certain targeted therapies known as EGFR tyrosine kinase inhibitors. You should discuss the clinical implications of this finding and any potential impact on treatment options with your oncologist or a qualified healthcare provider.
This genotype is extremely rare in the general population.
Typical EGFR gene profile
This genotype represents the common, non-mutated sequence at this position in the EGFR gene. It is considered the reference sequence in the general population and is not associated with the specific oncogenic changes linked to this variant. Please note that this profile refers only to this specific genetic location.
This is a common genotype found in the general population.
EGFR variant carrier
This genotype indicates the presence of one copy of the variant allele, which is associated with specific clinical responses in oncology, particularly in the context of non-small cell lung cancer. Research suggests this variant can influence sensitivity to certain targeted therapies known as EGFR tyrosine kinase inhibitors. You should discuss the clinical implications of this finding and any potential impact on treatment options with your oncologist or a qualified healthcare provider.
This genotype is rare in the general population.
What is rs121913428 and Where is it Located?
The single nucleotide polymorphism (SNP) rs121913428 is a specific variation in the DNA sequence found within the EGFR gene. SNPs represent the most common type of genetic variation, occurring when a single nucleotide differs in the DNA sequence among individuals. rs121913428 is a missense variant, meaning it results in a change of a single amino acid in the protein sequence. This particular SNP is located in the coding region of the EGFR gene, which is crucial for cell growth and division. Because it is a missense mutation, it has the potential to alter the structure or function of the resulting protein, which is why it is a subject of interest in clinical research regarding how cells respond to external signals and therapeutic interventions.
The Role of the EGFR Gene
The EGFR gene provides instructions for making a protein that acts as a receptor on the surface of cells. This receptor plays a vital role in cell growth, survival, and differentiation by binding to epidermal growth factor. When this factor binds to the EGFR, it triggers a cascade of signals inside the cell, leading to various cellular processes. Aberrant EGFR signaling is a hallmark of many cancers, making the EGFR pathway a significant target for cancer therapies. Because this gene is so central to the regulation of cell proliferation, variations within its sequence are frequently studied to understand how they might influence the behavior of cancer cells or the efficacy of drugs designed to inhibit this specific signaling pathway.
Research Associations: Oncology Treatment Response
rs121913428 has been investigated for its association with clinical responses in oncology, particularly concerning treatments that target the EGFR pathway. Studies have explored how the presence of this variant might influence the effectiveness of certain cancer drugs. The evidence strength is currently considered moderate, indicating that while there is a documented association, more research may be needed to fully elucidate the precise impact and clinical utility of this variant in predicting treatment outcomes. It is important to note that in the context of oncology, genetic variants are often studied to determine if they act as biomarkers for drug sensitivity or resistance. However, because the evidence is moderate, this variant is not currently used as a standalone diagnostic tool for determining treatment plans.
What This Information Means for You
Information about rs121913428 can offer insights into potential responses to specific cancer therapies. However, it is crucial to understand that a single genetic variant rarely determines a complex outcome like cancer treatment response. Many other genetic and environmental factors play a role. This information should not be used for self-diagnosis or to make treatment decisions. If you have received genetic testing results that mention this variant, it is essential to discuss these findings with your healthcare provider or a genetic counselor. They can help interpret the results in the context of your overall health, medical history, and current treatment plan. Never change or stop any prescribed medication based on genetic information without consulting your clinician or pharmacist first.
How common is this variant?
rs121913428 is a rare variant in general populations, meaning it is found in a small percentage of individuals. Specific genotype frequencies across diverse ancestral groups are not widely documented due to its rarity.
Frequently asked questions
What is an EGFR gene variant?
An EGFR gene variant is a specific difference in the DNA sequence of the EGFR gene compared to the most common sequence found in the population. These variants can potentially affect how the EGFR protein functions.
How does rs121913428 relate to cancer?
rs121913428 is a variant within the EGFR gene, which is frequently implicated in cancer development. Research suggests this specific variant may influence how individuals respond to certain cancer treatments targeting the EGFR pathway.
Is rs121913428 a common genetic variant?
No, rs121913428 is considered a rare genetic variant in general populations. Its infrequency can make it challenging to study its full impact across diverse groups.
Can I make treatment decisions based on rs121913428?
Genetic information like rs121913428 is complex and should not be used for self-diagnosis or to make treatment decisions. Always consult with a healthcare professional for personalized medical advice.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121913428?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29